• Particular attention will be given to novel solutions to address unmet needs for women’s health

• Drug delivery and manufacturing technologies that enable multiple new therapeutics and optimizes the patient experience (ex. advanced assembly of multi-specifics)
• Innovative digital and/or automated technologies to support life science operations:
          o automation, miniaturization, & high-throughput
          o data collection, utilization, & management

•   Novel vascular diagnostic and therapeutic medical devices
•   Novel endoscopic-related diagnostic and therapeutic medical devices

• Repurpose existing therapeutics as MCMs against chemical threats (cyanide, opioids, nerve agents, chlorine, sulfur mustard, etc.).
• Novel platform technologies and instrumentation for on-demand detection of multiple biochemical health markers
• Digital health diagnostic tools that can augment existing medical countermeasures against health security threats
• Therapies aimed at fortifying and restoring balance to the body’s defense mechanisms with a preference for multiplexed biochemical assays
• Novel technologies to sustain healthy oxygenation levels in ARDS patients
• Development of On Demand Vaccine Manufacturing technologies/systems for distributed vaccine production at or near the point-of-service, with a particular focus on nucleic acid-based vaccines
• Host-based diagnostics
• Repurposing existing FDA-approved and late-stage development therapeutics as potential MCMs for radiological and nuclear events

• Devices intended to simplify and improve therapeutic procedures in the women’s health space, filling treatment gaps and advancing patient care. Areas of interest include:
     • GYN transvaginal procedures, such as:
          o Tubal obstruction (HSG, selective HSG)
          o Biopsy collection
          o Vaginal Surgery
     • GYN Laparoscopic surgery
     • Pelvic organ prolapse
     • Pelvic/bladder health 
     • Contraception (non-hormonal)
     • Fertility
     • OR equipment management

• 3D Printing
• AFib
• Cardiovascular
• Digital Surgery
• Neurovascular
• Oncology
• Obesity
• Osteoarthritis
• Osteoporosis
• Sensor technologies
• Surgery
• Vision Care

Therapeutic interests:
     • Diabetes
     • Obesity
     • Cardiovascular disease
     • Non-alcoholic Steatohepatitis (NASH)
     • Chronic Kidney Disease 
     • Rare Blood Disorders
     • Rare Growth Disorders
Technology interests:
     • Disease agnostic innovative technology or biology approaches with potential to identify novel drug targets and/or drug modalities.
     • Drug modalities enabling transient and permanent gene modulation and editing
     • Tissue and cell type specific targeting of biologics, RNA therapeutics and Gene Editors
     • Devices and Delivery solutions (incl. alternative and sustained release solutions)
     • Digital Health solutions
     • Computational, AI/ML approaches to drug design and drug discovery
     • Translational approaches for drug discovery and development, incl. new biomarkers
     • Biologics production and upscale
     • High throughput screening approaches and automation
     • Stem Cell Therapies